Android Apple

Arcellx (ACLX) Surged in Q3. Here's Why

By Yahoo! Finance   |   1 month ago
Arcellx (ACLX) Surged in Q3. Here's Why

Baron Funds' "Baron Health Care Fund" Q3 2024 investor letter revealed a 5.81% appreciation. The top holding, Arcellx, Inc. (NASDAQ:ACLX), a biotech company focusing on cell therapies, showed significant growth potential.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.